Get started

Financials · CDLX

Cardlytics Inc. (CDLX) financials

For the twelve months ended Sep 30, 2026, Cardlytics Inc. reported $175.92M of revenue and -$36.55M of net income.

Revenue, TTM
$175.92M
Revenue growth, YoY
-25.3%
Net income, TTM
-$36.55M
Net margin
-20.8%
Free cash flow, TTM
-$7.20M
Cash
$29.95M
Total debt
$194.69M
P/S
0.06
Market cap
$9.9M
Annual revenue$233.27M
FY2016FY2025
Annual net income-$103.49M
FY2016FY2025
Annual free cash flow$8.81M
FY2016FY2025

CDLX revenue and earnings growth

CDLX revenueQ3 2026$32.88M

Quarter YoY
-30.0%
QoQ
-10.8%
FY YoY
-16.2%
5Y CAGR
+4.5%

CDLX revenue was $32.88M in fiscal Q3 2026 (ended Sep 30, 2026), down 30.0% from a year earlier and down 10.8% from the prior quarter. For the full fiscal 2025 it was $233.27M, down 16.2% from fiscal 2024. Compound annual growth was +4.5% over 5 years. It rose in 6 of the last 9 fiscal years.

CDLX net incomeQ3 2026-$8.95M

CDLX net income was -$8.95M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$72.67M a year earlier. For the full fiscal 2025 it was -$103.49M, compared with -$189.30M in fiscal 2024.

CDLX EPSQ3 2026-$1.26

CDLX diluted EPS was -$1.26 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$13.14 a year earlier. For the full fiscal 2025 it was -$1.95, compared with -$3.91 in fiscal 2024.

CDLX free cash flowQ3 2026-$5.92M

CDLX free cash flow was -$5.92M in fiscal Q3 2026 (ended Sep 30, 2026), compared with $1.75M a year earlier. For the full fiscal 2025 it was $8.81M, compared with -$10.39M in fiscal 2024. Fiscal 2025 is the highest of the 10 fiscal years on file.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$233.27M$278.30M$309.20M$298.54M$267.12M$186.89M$210.43M$150.68M$130.37M$112.82M
Research and development$39.77M$49.61M$51.35M$54.44M$38.10M$17.53M$11.70M$16.21M$12.15M$13.90M
Selling, general and admin$47.27M$56.48M$58.81M$81.45M$66.22M$46.53M$36.72M$34.23M$20.10M$21.36M
Operating income-$101.82M-$195.50M-$135.67M-$457.78M-$122.60M-$53.92M-$17.32M-$40.92M-$17.10M-$56.23M
Interest expense-$10.60M$8.90M$6.20M$4.00M------
Pre-tax income-$103.49M-$189.30M-$134.70M-$466.71M-$136.43M-$55.42M-$17.14M-$53.04M-$19.64M-$75.70M
Income tax$0$0$0-$1.45M-$7.86M$0$0$0$0$0
Net income-$103.49M-$189.30M-$134.70M-$465.26M-$128.56M-$55.42M-$17.14M-$53.04M-$19.64M-$75.70M
EPS, basic-$1.95-$3.91-$3.69-$13.92-$3.99-$2.04-$0.72-$2.79-$7.86-$32.48
EPS, diluted-$1.95-$3.91-$3.69-$13.92-$3.99-$2.04-$0.72-$2.79-$7.86-$32.48
Diluted shares53.1M48.4M36.5M33.4M32.2M27.2M23.7M19.1M3.2M2.4M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$48.72M$65.59M$91.83M$121.98M$233.56M$293.35M$104.59M$59.87M$21.26M$22.97M
Short-term investments$0---------
Receivables$82.46M$103.25M$120.62M$115.61M$111.08M$81.25M$81.45M$58.13M$48.35M-
Current assets$137.28M$177.98M$223.93M$250.04M$358.73M$385.59M$195.73M$124.37M$74.63M-
Goodwill$110.31M$159.43M$277.20M$352.72M$742.52M$0----
Total assets$285.64M$392.71M$574.14M$691.24M$1.26B$422.54M$224.31M$153.76M$100.76M-
Current liabilities$78.39M$148.96M$171.15M$248.94M$327.35M$81.27M$78.40M$51.92M$42.14M-
Short-term debt$0$45.86M$0$0-$13.0K$24.0K$21.0K$44.0K-
Long-term debt-----$174.01M$13.0K$46.69M$56.97M-
Total debt$208.92M$213.59M$257.50M$226.05M$184.40M$174.02M$37.0K$46.71M$57.01M-
Total liabilities$292.15M$322.72M$439.35M$479.63M$573.10M$265.35M$81.05M---
Shareholders' equity-$6.51M$69.99M$134.80M$211.60M$690.70M$157.19M$143.27M$51.98M-$208.69M-$216.84M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow$9.29M-$8.82M-$185.0K-$53.90M-$38.52M-$7.60M$11.46M-$19.00M-$22.10M-$32.50M
Capital expenditures$480.0K$1.56M$667.0K$1.17M$3.11M$5.41M$8.28M$5.92M$1.22M$1.83M
Free cash flow$8.81M-$10.39M-$852.0K-$55.08M-$41.63M-$13.01M$3.18M-$24.91M-$23.32M-$34.33M
Investing cash flow-$15.30M-$18.75M-$10.06M-$15.76M-$506.69M-$10.12M-$11.02M-$7.34M-$1.65M-$2.54M
Financing cash flow-$11.12M$1.44M-$20.03M-$39.99M$486.00M$206.43M$44.18M$65.19M$21.76M$30.81M
Share repurchases-$0$0$40.00M$0$0----
Stock-based compensation$28.13M$40.37M$40.98M$44.69M$50.26M$32.40M$15.85M$26.79M$5.15M$3.45M
Depreciation and amortization$25.24M$25.69M$26.46M$37.54M$29.87M$7.83M$4.54M$3.28M$3.03M$4.22M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY-16.2%-10.0%3.6%11.8%42.9%-11.2%39.6%15.6%15.6%-
Operating margin-43.6%-70.2%-43.9%-153.3%-45.9%-28.9%-8.2%-27.2%-13.1%-49.8%
Net margin-44.4%-68.0%-43.6%-155.8%-48.1%-29.7%-8.1%-35.2%-15.1%-67.1%
Free cash flow margin3.8%-3.7%-0.3%-18.4%-15.6%-7.0%1.5%-16.5%-17.9%-30.4%
Return on equity--270.5%-99.9%-219.9%-18.6%-35.3%-12.0%-102.1%--
Return on assets-36.2%-48.2%-23.5%-67.3%-10.2%-13.1%-7.6%-34.5%-19.5%-
Current ratio1.751.191.311.001.104.742.502.401.77-
Debt to equity-3.051.911.070.271.110.000.90--

Source: XBRL data Cardlytics Inc. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CDLX peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
CDLX$175.92M-25.3%-$36.55M-20.8%$9.9M
GOOGL$471.10B+22.2%$235.69B50.0%$3.53T
GOOG$471.10B+22.2%$235.69B50.0%$3.50T
META$241.61B+27.5%$75.25B31.1%$1.64T
APP$7.61B+57.8%$5.01B65.9%$131.04B
NBIS$529.80M+479.0%$82.50M15.6%$36.43B
BIDUCN¥129.08B-3.0%CN¥5.59B4.3%$27.12B

CDLX FAQ

7 questions
  • What is CDLX revenue?
    Cardlytics Inc. (CDLX) reported $175.92M of revenue for the twelve months ended Sep 30, 2026. That is down 25.3% from the year before. Revenue for fiscal 2025 was $233.27M.
  • Is CDLX profitable?
    No. Cardlytics Inc. reported a net loss of $36.55M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does CDLX have?
    Cardlytics Inc. reported $29.95M in cash and cash equivalents and $194.69M of debt on its most recent balance sheet in SEC filings.
  • How fast is CDLX revenue growing?
    Cardlytics Inc.'s revenue changed -16.2% in fiscal 2025, to $233.27M. Its compound annual growth rate was +4.5% over 5 years.
  • What is CDLX free cash flow?
    Cardlytics Inc. generated -$7.20M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$7.13M less capital expenditures.
  • When did CDLX last report financial results?
    The latest statements here come from Cardlytics Inc.'s 10-Q filed on Nov 5, 2026, covering the period ended Sep 30, 2026.
  • Where does this CDLX financial data come from?
    Quantisnow builds these statements from the structured XBRL data Cardlytics Inc. files with the SEC. It is provided for information only and is not investment advice.